SK3 Group stock analysis
SK3 Group (SKTO) Stock Price & Analysis
SKTO Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- $1,239
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- 0.0
- Beta
- 138.68
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
SKTO FAQ
What is SK3 Group’s market cap?
When is SK3 Group’s upcoming earnings report date?
Is SK3 Group overvalued?
Does SK3 Group pay dividends?
What is SK3 Group’s EPS estimate?
How many shares outstanding does SK3 Group have?
Which hedge fund is a major shareholder of SK3 Group?
What is the TipRanks Smart Score and how is it calculated?
Company Description
SK3 Group
SK3 Group, Inc. offers strategic consulting, product authorization, and promotional assistance to medical cannabis organizations situated in California. The company also grants licenses for the commercialization and distribution of a varied range of products. These include the YAK brand of medical marijuana edibles; Canna-Loz, an ingestion method for significant quantities of phyto-cannabinoids; Yeti, a pre-rolled item crafted for pain management; and Dharmanol, an exclusive technological process that isolates, stabilizes, and safeguards the beneficial cannabinoids from hemp and marijuana in their non-intoxicating form. Previously operating as CTT International Distributors, Inc., the company officially rebranded as SK3 Group, Inc. in May 2007. Founded in 2000, its main corporate base is located in Los Angeles, California. SK3 Group, Inc. is an affiliate of Healthcare of Today, Inc.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Artemus Mayor
- Employees
- 15
- Website
- www.sk3group.com
- Address
- 448 South Hill Street, Los Angeles, CA, 90013, US

